From vulnerable plaque to blood healthy therapy. - Wikidata - wikimedia - TriplyDB

From vulnerable plaque to blood healthy therapy.

From vulnerable plaque to blood healthy therapy.

http://www.wikidata.org/entity/Q50251747

about

From vulnerable plaque to blood healthy therapy.

http://www.wikidata.org/entity/Q50251747

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

From vulnerable plaque to blood healthy therapy.

@en

From vulnerable plaque to blood healthy therapy.

@nl

type

label

From vulnerable plaque to blood healthy therapy.

@en

From vulnerable plaque to blood healthy therapy.

@nl

prefLabel

From vulnerable plaque to blood healthy therapy.

@en

From vulnerable plaque to blood healthy therapy.

@nl

P1433

Q50251747-4A341701-1C72-4D51-8299-CDB7927DB86C

P1476

Q50251747-1D9CBB74-D4DB-434D-AC9F-445C2893A12E

P2093

Q50251747-64C9E5D0-B11A-41BE-9DAB-39D654CF22D8

Q50251747-C224937B-5C0D-4079-B625-49E6F929EB5F

P2860

Q50251747-018F0D03-7932-4793-B4E2-6F150ECE4941

Q50251747-0694E0CF-38CA-4C64-BE24-68A11B764590

Q50251747-1DAB6328-DADB-45A4-A4D6-C3AD34D9941C

Q50251747-20ADA364-FD98-4BEF-9ABF-99F0D7774898

Q50251747-283621C2-CA82-4596-8852-71350F3A67BF

Q50251747-3251B8FB-D173-4CC7-8354-835EC998D2AA

Q50251747-3C3D94D5-0116-4A8C-82AC-25811FE1DDEF

Q50251747-3D1A7B2B-53B3-4AE4-9C52-230EBE6EB154

Q50251747-3ECBEEE3-ABA9-41BE-8CE8-0E704E4F628D

Q50251747-4C8D8254-63BE-4712-A683-3243E9EFC86D

P304

Q50251747-B9313A6C-C54A-4D8E-B98A-03B7B6B32B51

P31

Q50251747-7E485EFD-2FEC-49ED-B63B-BC6123386ACE

P356

Q50251747-99CECAC9-CAC3-4024-ACEC-0805140468D4

P577

Q50251747-81B47642-06B3-46B2-93B5-E479F08EFB5C

P698

Q50251747-BA84D4DE-1416-4FB6-8BF5-A04FC840AF6F

P356

0267659117728113

P1433

P1476

From vulnerable plaque to blood healthy therapy.

@en

P2093

Sun Yuhua

http://www.w3.org/2001/XMLSchema#string

Wang Baoping

http://www.w3.org/2001/XMLSchema#string

P2860

The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment

Concept of vulnerable/unstable plaque.

Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

First data from the German Lipoprotein Apheresis Registry (GLAR).

Effect of isovolumic hemodilution on oxygen delivery to the optic nerve head.

Impact of the German Lipoprotein Apheresis Registry (DLAR) on therapeutic options to reduce increased Lp(a) levels

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

Relationship between Sustained Reductions in Plasma Lipid and Lipoprotein Concentrations with Apheresis and Plasma Levels and mRNA Expression of PTX3 and Plasma Levels of hsCRP in Patients with HyperLp(a)lipoproteinemia.

P304

267659117728113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0267659117728113

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28856989

http://www.w3.org/2001/XMLSchema#string